Up 43% In A Month, Will UniQure Stock See Further Gains?
- Tuesday, July 12, 2022, 7:12
- Market
- Add a comment
This can be attributed to the company reporting positive findings from clinical trials for its Huntington’s Disease treatment – AMT-130.
About the Author
admin123 has written 23527 stories on this site.
